Intriguingly, ROS enhancement driven by mutant p53 might represent an “Achilles heel” of cancer cells carrying mutant TP53 gene, as revealed by the mutp53-dependent acquisition of cell sensitivity to H2O2 treatment [8]. The gene discussed is TP53; the disease is cancer.